PLK1 also phosphorylates MRE11 on S649, and prostate cancer cells (U2OS) expressing phosphomimetic MRE11 have a 5-fold increased sensitivity to olaparib, both in vitro and in vivo [40]. This evidence concerns the gene PLK1 and Familial prostate cancer.